PDE5-IN-2 structure
|
Common Name | PDE5-IN-2 | ||
---|---|---|---|---|
CAS Number | 2244517-61-9 | Molecular Weight | 491.52 | |
Density | N/A | Boiling Point | N/A | |
Molecular Formula | C25H21N3O6S | Melting Point | N/A | |
MSDS | N/A | Flash Point | N/A |
Use of PDE5-IN-2PDE5-IN-2 is a potent, highly selective, and orally active PDE5 inhibitor, with an IC50 of 0.31 nM, less potently inhibits PDE2A, PDE10A, PDE4D2, and PDE6C, with IC50s of 106, 46, 43, 1.2 nM, respectively. Anti-pulmonary arterial hypertension activity[1]. |
Name | PDE5-IN-2 |
---|
Description | PDE5-IN-2 is a potent, highly selective, and orally active PDE5 inhibitor, with an IC50 of 0.31 nM, less potently inhibits PDE2A, PDE10A, PDE4D2, and PDE6C, with IC50s of 106, 46, 43, 1.2 nM, respectively. Anti-pulmonary arterial hypertension activity[1]. |
---|---|
Related Catalog | |
Target |
PDE5A1:0.31 nM (IC50) PDE6C:1.2 nM (IC50) PDE4D2:43 nM (IC50) PDE10A:46 nM (IC50) PDE2A:106 nM (IC50) |
In Vitro | PDE5-IN-2 (Compound 3) has at least 1000-fold selectivity over PDE1B, PDE3A, PDE7A1, PDE8A1, and PDE9A2 (IC50s, >32 000 nM)[1]. |
In Vivo | PDE5-IN-2 (1.25 mg/kg, p.o.) shows anti-pulmonary arterial hypertension activity, decreases mean pulmonary artery pressure in rats[1]. |
References |
Molecular Formula | C25H21N3O6S |
---|---|
Molecular Weight | 491.52 |